What is the recommended dose and duration of cefdinir (Omnicef) for pediatric ear infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefdinir Dosing for Pediatric Acute Otitis Media

For pediatric ear infections (acute otitis media), cefdinir should be dosed at 7 mg/kg every 12 hours OR 14 mg/kg once daily for 5-10 days, with the once-daily regimen studied specifically for 10 days. 1

FDA-Approved Dosing Regimens

The FDA label provides two equivalent dosing options for acute bacterial otitis media in children 6 months through 12 years 1:

  • Twice-daily dosing: 7 mg/kg every 12 hours for 5-10 days 1
  • Once-daily dosing: 14 mg/kg every 24 hours for 10 days 1

The total daily dose for all infections is 14 mg/kg, up to a maximum of 600 mg per day 1. Children weighing ≥43 kg should receive the maximum daily dose of 600 mg 1.

Practical Dosing Examples

Using the FDA dosage chart 1:

  • 9 kg (20 lbs): 2.5 mL of 125 mg/5 mL suspension every 12 hours OR 5 mL once daily
  • 18 kg (40 lbs): 5 mL of 125 mg/5 mL suspension every 12 hours OR 10 mL once daily
  • 27 kg (60 lbs): 7.5 mL of 125 mg/5 mL suspension every 12 hours OR 15 mL once daily
  • 36 kg (80 lbs): 10 mL of 125 mg/5 mL suspension every 12 hours OR 20 mL once daily

Duration of Therapy: Critical Consideration

A major caveat exists regarding the 5-day regimen: While the FDA label states 5-10 days for acute otitis media 1, and one study showed equivalence between 5-day cefdinir and 10-day cefprozil 2, more recent head-to-head data reveals important limitations:

  • 10 days of high-dose amoxicillin/clavulanate (86.5% cure) significantly outperformed 5 days of cefdinir (71.0% cure) in children 6-24 months with AOM 3
  • Cefdinir efficacy decreased with increasing age/weight, suggesting the standard dose may be inadequate in older/heavier children 3
  • The once-daily 10-day regimen has been specifically studied and validated 1, whereas the 5-day regimen's efficacy appears questionable based on comparative data 3

Therefore, the 10-day once-daily regimen (14 mg/kg daily) is the safer choice to optimize clinical cure rates and minimize treatment failure.

Administration Details

  • Cefdinir may be administered without regard to meals 1
  • The suspension should be shaken well before each dose 1
  • After reconstitution, store at room temperature (25°C/77°F) in a tightly closed container 1
  • Discard any unused suspension after 10 days 1

Special Populations

For pediatric patients with renal insufficiency (creatinine clearance <30 mL/min/1.73 m²), reduce the dose to 7 mg/kg (up to 300 mg) once daily 1.

For patients on hemodialysis, give 7 mg/kg every other day, with an additional dose (7 mg/kg) at the conclusion of each hemodialysis session 1.

Clinical Context and Alternatives

While cefdinir is listed as an alternative for β-lactamase-producing Haemophilus influenzae in pneumonia guidelines 4, it is not a first-line agent for acute otitis media. The evidence suggests that when bacterial treatment is indicated for AOM, high-dose amoxicillin or amoxicillin/clavulanate remains superior 3. Cefdinir serves as a reasonable second-line option for penicillin-allergic patients or in cases of treatment failure with amoxicillin 5, but prescribers should be aware of its lower cure rates compared to first-line agents 3.

The drug's superior palatability compared to other oral antibiotics may improve adherence in children who have failed other therapies due to taste-related noncompliance 6, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.